Compare Medtronic PLC (MDT) vs ProShares Ultra QQQ ETF (QLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs ProShares Ultra QQQ ETF — how do they compare? Medtronic PLC trades at $82.56 (market cap $106.61B), while ProShares Ultra QQQ ETF trades at $89.27. The key difference: Medtronic PLC pays a 3.46% dividend while ProShares Ultra QQQ ETF pays none, and ProShares Ultra QQQ ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | QLD | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $100.53 |
52-Week Low | $73.75 | $57.16 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
QLD, the ProShares Ultra QQQ ETF, trades at $86.06, up 0.17% on the day. The technical outlook is bearish, with moving averages signaling a downtrend and key support at $85. Recent articles highlight its long-term performance, with over 10,000% total return since inception, but caution its leveraged structure amplifies risks, evidenced by a historical maximum drawdown exceeding 63%.
The outlook for QLD is heavily tied to the performance of the Nasdaq-100 index. While leveraged exposure offers potential for amplified gains during tech rallies, the daily reset mechanism poses significant volatility and decay risks in choppy markets. Investor focus remains on upcoming tech earnings and broader market trends for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About ProShares Ultra QQQ ETF
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →
